Relationship to insulin resistance of the adult treatment panel III diagnostic criteria for identification of the metabolic syndrome - PubMed (original) (raw)
Clinical Trial
. 2004 May;53(5):1195-200.
doi: 10.2337/diabetes.53.5.1195.
Affiliations
- PMID: 15111486
- DOI: 10.2337/diabetes.53.5.1195
Clinical Trial
Relationship to insulin resistance of the adult treatment panel III diagnostic criteria for identification of the metabolic syndrome
Karen L Cheal et al. Diabetes. 2004 May.
Abstract
The Adult Treatment Panel III (ATP III) has published criteria for diagnosing the metabolic syndrome, a cluster of closely related abnormalities related to insulin resistance that increase cardiovascular disease risk. The present analysis was performed to evaluate the ability of these criteria to identify insulin-resistant individuals. The population consisted of 443 healthy volunteers, with measurements of BMI, blood pressure, fasting plasma glucose, triglycerides, HDL cholesterol concentrations, and steady-state plasma glucose (SSPG) concentration. Insulin resistance was defined as being in the top tertile of SSPG concentrations. Of the population, 20% satisfied ATP III criteria for the metabolic syndrome. Although insulin resistance and the presence of the metabolic syndrome were significantly associated (P < 0.001), the sensitivity and positive predictive value equaled 46% (69 of 149) and 76% (69 of 91), respectively. Being overweight, with high triglycerides, low HDL cholesterol, or elevated blood pressure, most often resulted in a diagnosis of the metabolic syndrome. Thus, the ATP III criteria do not provide a sensitive approach to identifying insulin-resistant individuals. The individual components vary both in terms of their utility in making a diagnosis of the metabolic syndrome and their relationship to insulin resistance, with the obesity and lipid criteria being most useful.
Similar articles
- Use of metabolic markers to identify overweight individuals who are insulin resistant.
McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G. McLaughlin T, et al. Ann Intern Med. 2003 Nov 18;139(10):802-9. doi: 10.7326/0003-4819-139-10-200311180-00007. Ann Intern Med. 2003. PMID: 14623617 - Correspondence between the adult treatment panel III criteria for metabolic syndrome and insulin resistance.
Sierra-Johnson J, Johnson BD, Allison TG, Bailey KR, Schwartz GL, Turner ST. Sierra-Johnson J, et al. Diabetes Care. 2006 Mar;29(3):668-72. doi: 10.2337/diacare.29.03.06.dc05-0970. Diabetes Care. 2006. PMID: 16505524 - Identifying subjects with insulin resistance by using the modified criteria of metabolic syndrome.
Hsieh CH, Pei D, Hung YJ, Kuo SW, He CT, Lee CH, Wu CZ. Hsieh CH, et al. J Korean Med Sci. 2008 Jun;23(3):465-9. doi: 10.3346/jkms.2008.23.3.465. J Korean Med Sci. 2008. PMID: 18583884 Free PMC article. - The metabolic syndrome: is this diagnosis necessary?
Reaven GM. Reaven GM. Am J Clin Nutr. 2006 Jun;83(6):1237-47. doi: 10.1093/ajcn/83.6.1237. Am J Clin Nutr. 2006. PMID: 16762930 Review. - The metabolic syndrome, hyperlipidemia, and insulin resistance.
Fonseca VA. Fonseca VA. Clin Cornerstone. 2005;7(2-3):61-72. doi: 10.1016/s1098-3597(05)80069-9. Clin Cornerstone. 2005. PMID: 16473262 Review.
Cited by
- Metabolic Syndrome and Menopause: The Impact of Menopause Duration on Risk Factors and Components.
Erdoğan K, Sanlier N. Erdoğan K, et al. Int J Womens Health. 2024 Jul 24;16:1249-1256. doi: 10.2147/IJWH.S460645. eCollection 2024. Int J Womens Health. 2024. PMID: 39070300 Free PMC article. - The impact of insulin resistance on the association between metabolic syndrome and lung function: the Kangbuk Samsung Health Study.
Lee J, Park HK, Kwon MJ, Ham SY, Gil HI, Lim SY, Song JU. Lee J, et al. Diabetol Metab Syndr. 2023 Apr 1;15(1):65. doi: 10.1186/s13098-023-01042-9. Diabetol Metab Syndr. 2023. PMID: 37005609 Free PMC article. - Significance of Lipid Profile Parameters in Predicting Pre-Diabetes.
Jasim OH, Mahmood MM, Ad'hiah AH. Jasim OH, et al. Arch Razi Inst. 2022 Feb 28;77(1):277-284. doi: 10.22092/ARI.2021.356465.1846. eCollection 2022 Feb. Arch Razi Inst. 2022. PMID: 35891716 Free PMC article. - Comparing Digital Therapeutic Intervention with an Intensive Obesity Management Program: Randomized Controlled Trial.
Moravcová K, Karbanová M, Bretschneider MP, Sovová M, Ožana J, Sovová E. Moravcová K, et al. Nutrients. 2022 May 10;14(10):2005. doi: 10.3390/nu14102005. Nutrients. 2022. PMID: 35631145 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical